Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90
   PubMed Web of Science ®Google Scholar
• Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, et al. Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity. J Surg Oncol 2011; 104: 692–698
   PubMed Web of Science ®Google Scholar
• Chen J, Su Y, Song Z, Lin LM. Clinical application of postoperative intraperitoneal hyperthermic perfusion combined with venoclysis for gastric cancer. Chin J Cancer Prev Treat 2006; 13: 937–938
   Google Scholar
• Chen SR, Zhao F, Tan ZW, Lv JS. Efficacy of intraoperative hyperthermic intraperitoneal chemotherapy for patients with advanced gastric carcinoma. J Youjiang Med Coll Nation 2005; 27: 357
   Google Scholar
• Chen ZX, Hu JK, Cheng Z, Chen JP, Peng DS, Tao QP. Positive results of therapy of gastric cancer patients after operation by intraperitoneal hyperthermic chemotherapy. J Chin Pract Med 2001; 3: 39–40 & 44
   Google Scholar
• Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999; 85: 529–534
   PubMed Web of Science ®Google Scholar
• Fujimura T, Yonemura Y, Muraoka K, Takamura H, Hirono Y, Sahara H, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study. World J Surg 1994; 18: 150–155
   PubMed Web of Science ®Google Scholar
• Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994; 73: 2048–2052
   PubMed Web of Science ®Google Scholar
• Jin YF. Efficacy of intraoperative hyperthermic intraperitoneal chemotherapy for patients with advanced gastric carcinoma. Zhejiang J Clin Med 2007; 9: 357–358
   Google Scholar
• Wang FL, Hou AJ, Peng Z. Clinical study of hypotonic intraoperative intraperitoneal chemohyperthermia for gastric cancer. Clin J Med Offic 2006; 34: 17–19
   Google Scholar
• Wang MY, Sun G, Zhou JP, He FL. Clinical application of intraperitoneal hyperthermia chemoperfusion in the operation for the advanced gastric cancer. World J Med Today 2002; 3: 293–294
   Google Scholar
• Wang SW. The analysis for curative effect of intraoperative hyperthermic intraperitoneal chemotherapy combined with postoperative veins chemotherapy. Chron Pathem J (China) 2010; 12: 404–405
   Google Scholar
• Ye L, Jiang T, Hu D, Xiong GY. Application of intraperitoneal peirtoneal hyperthermia chemoperfusion in advanced gastric cancer. Int Med Health Guid News (China) 2007; 13: 29–31
   Google Scholar
• Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura K, Sawa T, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995; 19: 450–454, discussion: 455
   PubMed Web of Science ®Google Scholar
• Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: Final results of a randomized controlled study. Hepatogastroenterology 2001; 48: 1776–1782
   PubMedGoogle Scholar
• Zhang GY, Chen XC, Pan K, Xia LG, Zuo M, Zheng T. Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer. Chin J Gastrointest Surg 2007; 10: 362–364
   Google Scholar
• Zhan HJ, Liang H, Wang BG, Deng JY, Hao XS. Efficacy of intraoperative hyperthermic peritoneal perfusion on 60 patients with advanced gastric carcinoma. Chin J Clin Oncol 2010; 37: 229–231
   Google Scholar
• Zhang WS, Su DM, Wang K, Yi PT, Zhou HT, Guo JJ. Clinical study of intraoperative hyperthermic intraperitoneal chemotherapy for preventing the peritoneal recurrence of advanced gastric carcinoma. Shanxi Med J 1998; 27: 67–69
   Google Scholar
• Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007; 99: 601–607
   PubMedGoogle Scholar
• Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725–730
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11–20
   PubMed Web of Science ®Google Scholar
• Eppink B, Krawczyk PM, Stap J, Kanaar R. Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies. Int J Hyperthermia 2012; 28: 509–517
   PubMed Web of Science ®Google Scholar
• Routt SM, Zhu J, Zaleski JM, Dynlacht JR. Potentiation of metalloenediyne cytotoxicity by hyperthermia. Int J Hyperthermia 2011; 27: 435–444
   PubMed Web of Science ®Google Scholar
• Frey B, Weiss EM, Rubner Y, Wunderlich R, Ott OJ, Sauer R, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 2012; 28: 528–542
   PubMed Web of Science ®Google Scholar
• Knippertz I, Stein MF, Dorrie J, Schaft N, Muller I, Deinzer A, et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperthermia 2011; 27: 591–603
   PubMed Web of Science ®Google Scholar
• Mace TA, Zhong L, Kokolus KM, Repasky EA. Effector CD8+ T cell IFN-gamma production and cytotoxicity are enhanced by mild hyperthermia. Int J Hyperthermia 2012; 28: 9–18
   PubMed Web of Science ®Google Scholar
• Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007; 14: 2702–2713
   PubMed Web of Science ®Google Scholar
• Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004; 10: 2727–2730
   PubMed Web of Science ®Google Scholar
• Tan CQ, Wang XJ, Xu YK, Jiang BN, Zeng FH. Clinical studies on prevention of post-operational intraperitoneal neoplasm seeding of advanced gastric cancer by surgery combined with intraperitoneal perfusion of hyperthermic mitomycin C. J Pract Oncol 2000; 15: 165–168
   Google Scholar
• Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Gastric cancer treatment: A systematic review. Oncol Rep 2004; 11: 911–916
   PubMed Web of Science ®Google Scholar
• Li W, Qin J, Sun YH, Liu TS. Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis. World J Gastroenterol 2010; 16: 5621–5628
   PubMed Web of Science ®Google Scholar
• Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials. Eur J Cancer 1999; 35: 1059–1064
   PubMed Web of Science ®Google Scholar
• Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000; 11: 837–843
   PubMed Web of Science ®Google Scholar
• Liu TS, Wang Y, Chen SY, Sun YH. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol 2008; 34: 1208–1216
   PubMed Web of Science ®Google Scholar
• Chen XZ, Yang K, Liu J, Chen XL, Hu JK. Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer. World J Gastroenterol 2011; 17: 4542–4544
   PubMed Web of Science ®Google Scholar
• Ikeguchi M, Kondou A, Oka A, Tsujitani S, Maeta M, Kaibara N. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg 1995; 161: 581–586
   PubMedGoogle Scholar
• Lu Q, Huang XJ, Luo YF, Yang DS, Chen C. Intraoperative intraperitoneal hypotonic thermoperfusion chemotherapy for advanced gastric cancer. J Clin Experim Med 2007; 6: 29–30
   Google Scholar
• Luo YF, Lu Q, Huang XJ, Yang DS, Chen C. Countermeasures of nursing in advanced gastric cancer by intraoperative intraperitoneal hypotonic thermoperfusion chemotherapy. Int Med Health Guid News (China) 2008; 14: 125–127
   Google Scholar
• Zhang B, Jiang ZH, Fang XD, Hong Y. Influence of hypotonic intraoperative intraperitoneal chemohyperthermia (HIPCH) on the long term survival of patients with gastric cancer. Chin J Gastrointest Surg 2004; 7: 289–291
   Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–497
   PubMed Web of Science ®Google Scholar
• Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1–18
   PubMed Web of Science ®Google Scholar
• Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: Systematic review of current results. J Cancer Res Clin Oncol 2009; 135: 1637–1645
   PubMed Web of Science ®Google Scholar
• De Haas-Kock DF, Buijsen J, Pijls-Johannesma M, Lutgens L, Lammering G, van Mastrigt GA, et al. Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer. Cochrane Database Syst Rev 2009; 3: CD006269
   PubMed Web of Science ®Google Scholar
• Lutgens L, van der Zee J, Pijls-Johannesma M, De Haas-Kock DF, Buijsen J, Mastrigt GA, et al. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. Cochrane Database Syst Rev 2010; 1: CD006377
   PubMedGoogle Scholar
• Sakurai H, Hayakawa K, Mitsuhashi N, Tamaki Y, Nakayama Y, Kurosaki H, et al. Effect of hyperthermia combined with external radiation therapy in primary non-small cell lung cancer with direct bony invasion. Int J Hyperthermia 2002; 18: 472–483
   PubMed Web of Science ®Google Scholar
• Hua Y, Ma S, Fu Z, Hu Q, Wang L, Piao Y. Intracavity hyperthermia in nasopharyngeal cancer: A phase III clinical study. Int J Hyperthermia 2011; 27: 180–186
   PubMed Web of Science ®Google Scholar
• Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ. The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study. Int J Hyperthermia 2011; 27: 27–32
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Kokura S, Sakamoto N, Ando T, Imamoto E, Hattori T, et al. Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer. Int J Hyperthermia 2012; 28: 597–604
   PubMed Web of Science ®Google Scholar
• Bergs JW, Franken NA, Haveman J, Geijsen ED, Crezee J, van Bree C. Hyperthermia, cisplatin and radiation trimodality treatment: A promising cancer treatment? A review from preclinical studies to clinical application. Int J Hyperthermia 2007; 23: 329–341
   PubMed Web of Science ®Google Scholar
• Mi DH, Li Z, Yang KH, Tian JH, Wang DY. HRCT for non-small cell lung cancer: A meta-analysis. Chin J Evidence-Based Med 2011; 11: 1262–1267
   Google Scholar
• Sugimachi K, Kitamura K, Baba K, Ikebe M, Morita M, Matsuda H, et al. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus – A prospective randomized trial. Int J Hyperthermia 1992; 8: 289–295
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial. Int J Hyperthermia 1994; 10: 485–493
   PubMed Web of Science ®Google Scholar
• Hulshof MC, Van Haaren PM, Van Lanschot JJ, Richel DJ, Fockens P, Oldenborg S, et al. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer. Int J Hyperthermia 2009; 25: 79–85
   PubMed Web of Science ®Google Scholar
• Kang MK, Kim MS, Kim JH. Clinical outcomes of mild hyperthermia for locally advanced rectal cancer treated with preoperative radiochemotherapy. Int J Hyperthermia 2011; 27: 482–490
   PubMed Web of Science ®Google Scholar
• Ghahremani FH, Sazgarnia A, Bahreyni-Toosi MH, Rajabi O, Aledavood A. Efficacy of microwave hyperthermia and chemotherapy in the presence of gold nanoparticles: An in vitro study on osteosarcoma. Int J Hyperthermia 2011; 27: 625–636
   PubMed Web of Science ®Google Scholar
• Golneshan AA, Lahonian M. The effect of magnetic nanoparticle dispersion on temperature distribution in a spherical tissue in magnetic fluid hyperthermia using the lattice Boltzmann method. Int J Hyperthermia 2011; 27: 266–274
   PubMed Web of Science ®Google Scholar
• Ishihara Y, Ohwada H. Non-invasive temperature measurement by using phase changes in electromagnetic waves in a cavity resonator. Int J Hyperthermia 2011; 27: 726–736
   PubMed Web of Science ®Google Scholar
• Raoof M, Zhu C, Kaluarachchi WD, Curley SA. Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: Developing an intracellular thermometer. Int J Hyperthermia 2012; 28: 202–209
   PubMed Web of Science ®Google Scholar
• van Dongen KW, Verweij MD. A feasibility study for non-invasive thermometry using non-linear ultrasound. Int J Hyperthermia 2011; 27: 612–624
   PubMed Web of Science ®Google Scholar